APA

Pivonello C., Patalano R., Solari D., Auriemma R. S., Frio F., Vitulli F., Grasso L. F. S., Di Cera M., De Martino M. C., Cavallo L. M., Cappabianca P., Colao A. & Pivonello R. (20190411). Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting. : Endocrine.

Chicago

Pivonello Claudia, Patalano Roberta, Solari Domenico, Auriemma Renata S, Frio Federico, Vitulli Francesca, Grasso Ludovica F S, Di Cera Marialuisa, De Martino Maria Cristina, Cavallo Luigi M, Cappabianca Paolo, Colao Annamaria and Pivonello Rosario. 20190411. Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting. : Endocrine.

Harvard

Pivonello C., Patalano R., Solari D., Auriemma R. S., Frio F., Vitulli F., Grasso L. F. S., Di Cera M., De Martino M. C., Cavallo L. M., Cappabianca P., Colao A. and Pivonello R. (20190411). Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting. : Endocrine.

MLA

Pivonello Claudia, Patalano Roberta, Solari Domenico, Auriemma Renata S, Frio Federico, Vitulli Francesca, Grasso Ludovica F S, Di Cera Marialuisa, De Martino Maria Cristina, Cavallo Luigi M, Cappabianca Paolo, Colao Annamaria and Pivonello Rosario. Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting. : Endocrine. 20190411.